Financial “hocus pocus” and the (potential) effectiveness of Prostvac VF

If readers come across a report this week suggesting that Barvarian Nordic’s Prostvac VF is likely to fail in the demonstration of effectiveness in its ongoing Phase III trial, you might want to treat that report with some caution. … READ MORE …

A sad manipulation of data to support a point of view

Dr. William Catalona has long been one of the strongest advocates of prostate cancer screening. He has been a key individual in the development and promotion of PSA testing for some 20 years, and he believes passionately that prostate cancer screening saves lives. We respect his beliefs and his right to express those beliefs. … READ MORE …